Publications
-
01
Effects of the novel compound DK223 on migration and proliferation of human keratinocytes and primary dermal fibroblasts,
2014, International Journal of Molecular Sciences 15, 13091-13110 -
02
Soy isoflavone glicitin(4’-hydroxy-6-methoxyisoflavone-7-D-glucoside) promotes human dermal fibroblast cell proliferation and migration via TGF-β signaling,
2015, Phytotherapy research, 29, 757-769 -
03
Dexamethasone inhibits TGF-β1-induced cell migration by regulating the ERK and AKT Pathways in Human Colon Cancer cells via Cyr61,
2016, Cancer Res Treat. 48(3): 1141-1153 -
04
A novel synthetic material, BMM, accelerates wound repair by stimulating re-epithelialization and fibroblast activation,
2018, Int J Mol Sci, 19(4), 1164 -
05
SIRT-1 regulates TGF-β-induced dermal fibroblast migration via modulation of Cyr61 expression,
2018, Connective Tissue Research, 59:3, 245-254 -
06
TM4SF5-mediated CD44v8-10 splcing variant promotes survival of type II alveolar epithelial cells during idiopathic pulmonary fibrosis,
2019, Cell Death & Disease, 10(9), 645 -
07
Cellular senescence and EMT crosstalk in bleomycin-induced pathogenesis of pulmonary fibrosis – an in vitro analysis,
2019, Cell biology international, -
08
Role of NAPDH oxidase and its therapeutic intervention in TGF-β-mediated EMT progression : an in vitro analysis on HeLa cervical cancer cells,
2020, Applied Biological Chemistry, 63(1):1-8 -
09
Redox Regulation of NOX Isoforms on FAK(Y397)/SRC(Y416) Phosphorylation Driven Epithelial-to-Mesenchymal Transition in Malignant Cervical Epithelial Cells,
2020, Cells 9(6)
Patents
No. | Title of Patent | Application/Registration | Country | Date | Application No./Registration No. |
01 |
Composition for Improving Pulmonary Fibrosis Using |
Registration | Korea | 17th, August, 2022 | 10-2292362 |
Application | PCT | 6th, July, 2021 | PCT/KR 2021/008552 | ||
Application | USA | 19th, November, 2021 | 17/612,712 | ||
02 |
Composition for Improving Pulmonary Fibrosis Using |
Application | Korea | 5th, July, 2021 | 10-2021-0087826 |
03 |
Composition for Improving Pulmonary Fibrosis Using |
Application | Korea | 30th, December, 2021 | 10-2022-0137147 |
Application | PCT | 29th, December, 2022 | PCT/KR 2022/021678 | ||
04 |
Method for Screening Drug Candidates for Treating |
Application | Korea | 8th, February, 2022 | 10-2022-0016475 |